Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human alpha A Crystallin aa 1-100. The exact sequence is proprietary.
Database link: P02489
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
Our Abpromise guarantee covers the use of ab181866 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB | 1/1000 - 1/2000. Predicted molecular weight: 20 kDa. | |
ICC/IF | 1/500. |
Immunofluorescence analysis of Y79 cells fixed with acetone labeling alpha A Crystallin with ab181866 at 1/500 dilution followed by Goat anti rabbit IgG(Alexa Fluor®555) at 1/200 dilution and counterstained with Dapi.
ab181866 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"